Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GILEAD SCIENCES, INC.

(GILD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Gilead Sciences, Inc.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Number of employees : 13 600 people.
Sales per Business
20192020Delta
Innovative Medicines22 449.00100.6%24 689.00100.2% +9.98%
USD in Million
Sales per region
20192020Delta
United States16 645.0074.6%18 217.0073.9% +9.44%
Europe3 811.0017.1%4 135.0016.8% +8.5%
Other International1 993.008.9%2 337.009.5% +17.26%
USD in Million
Managers
Name Title Age Since
Daniel O'Day Chairman & Chief Executive Officer 56 2019
Andrew Dickinson Chief Financial Officer 50 2019
Merdad Parsey Chief Medical Officer 57 2019
Flavius Martin Executive Vice President-Research - 2021
Brett Pletcher Secretary, Chief Compliance Officer & Executive VP 53 -
Kevin E. Lofton Lead Independent Director 65 2020
Kelly A. Kramer Independent Director 52 2016
Jacqueline K. Barton, Dr. Independent Director 67 2018
Harish M. Manwani Independent Director 66 2018
Sandra J. Horning, Dr. Independent Director 71 2020
Members of the board
Name Title Age Since
Daniel O'Day Chairman & Chief Executive Officer 56 2019
Kevin E. Lofton Lead Independent Director 65 2020
Kelly A. Kramer Independent Director 52 2016
Jacqueline K. Barton, Dr. Independent Director 67 2018
Harish M. Manwani Independent Director 66 2018
Sandra J. Horning, Dr. Independent Director 71 2020
Javier Rodriguez Independent Director 49 2020
Anthony Welters Independent Director 65 2020
Jeffrey A. Bluestone, Dr. Independent Director 66 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,254,000,000 1,252,971,467 99.9% 0 0.0% 99.9%
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 122,606,338 9.78%
The Vanguard Group, Inc. 98,719,082 7.87%
Capital Research & Management Co. 64,780,000 5.17%
SSgA Funds Management, Inc. 53,469,772 4.26%
Capital Research & Management Co. (International Investors) 40,030,211 3.19%
Capital Research & Management Co. (World Investors) 35,083,494 2.80%
BlackRock Fund Advisors 32,020,875 2.55%
Geode Capital Management LLC 20,671,306 1.65%
Dodge & Cox 18,462,150 1.47%
Northern Trust Investments, Inc.(Investment Management) 15,129,146 1.21%
Holdings
NameEquities%Valuation
GALAPAGOS NV (GLPG) 16,707,477 25.5% 1,158,687,422 USD
ARCUS BIOSCIENCES, INC. (RCUS) 13,913,029 19.6% 382,051,776 USD
ALLOGENE THERAPEUTICS, INC. (ALLO) 7,486,689 5.29% 195,252,849 USD
AGENUS INC. (AGEN) 11,111,111 5.00% 60,999,999 USD
JOUNCE THERAPEUTICS, INC. (JNCE) 5,539,727 10.8% 37,670,144 USD
HOOKIPA PHARMA INC. (HOOK) 2,092,799 8.05% 19,170,039 USD
SIERRA ONCOLOGY, INC. (SRRA) 725,283 5.87% 14,121,260 USD
Markets and indexes
- Nasdaq Global Select Market
- Nasdaq 100 / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  GILD:US
- Reuters Code :  GILD.O
- Datastream Code :  @GILD
Company contact information
Gilead Sciences, Inc.
333 Lakeside Drive
CA 94404 San Mateo, California

Phone : +1 650 574 3000
Fax : +1 650 578 9264
web site : http://www.gilead.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Gilead Sciences, Inc.
Sector Bio Therapeutic Drugs